Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
Cash Interest Paid
Atara Biotherapeutics Inc
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Cash Interest Paid
$447k
|
CAGR 3-Years
95%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Interest Paid
$2.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Interest Paid
$891m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Interest Paid
$43.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
15%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Cash Interest Paid?
Cash Interest Paid
447k
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Cash Interest Paid amounts to 447k USD.
What is Atara Biotherapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
13%
Over the last year, the Cash Interest Paid growth was 31%. The average annual Cash Interest Paid growth rates for Atara Biotherapeutics Inc have been 95% over the past three years , 13% over the past five years .